JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $8
Benzinga Newsdesk 4 days ago
Analyst RatingsNewsPrice Target
JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $10 to $8.
JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $10 to $8.